Trinity Biotech (TRIB) Inventory (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Inventory for 9 consecutive years, with $19.4 million as the latest value for Q4 2024.
- Quarterly Inventory fell 2.8% to $19.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $19.4 million through Dec 2024, down 2.8% year-over-year, with the annual reading at $19.4 million for FY2024, 2.8% down from the prior year.
- Inventory hit $19.4 million in Q4 2024 for Trinity Biotech, down from $19.9 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $30.2 million in Q4 2020 to a low of $19.4 million in Q4 2024.
- Historically, Inventory has averaged $24.2 million across 5 years, with a median of $22.5 million in 2022.
- Biggest five-year swings in Inventory: decreased 22.73% in 2022 and later dropped 2.8% in 2024.
- Year by year, Inventory stood at $30.2 million in 2020, then decreased by 3.63% to $29.1 million in 2021, then fell by 22.73% to $22.5 million in 2022, then fell by 11.42% to $19.9 million in 2023, then decreased by 2.8% to $19.4 million in 2024.
- Business Quant data shows Inventory for TRIB at $19.4 million in Q4 2024, $19.9 million in Q4 2023, and $22.5 million in Q4 2022.